Physician profile
Robert Q Ingraham
NPI 1609856269
$1,669.20
in general payments reported to CMS, 2019-2025
14 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $800 · 2021: $112 · 2022: $218 · 2023: $356 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microaire Surgical Instruments LLC | $800.00 | 2020 | |
| Cerapedics INC. | $406.37 | 2022-2023 | I-Factor Peptide Enhanced Bone Graft |
| Medacta USA, INC. | $107.72 | 2022 | |
| Nanohive Medical LLC | $88.91 | 2021 | |
| Si-Bone, INC. | $51.27 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $47.78 | 2025 | Iovera, Zilretta |
| Stryker Corporation | $29.82 | 2023 | Omnicurve, Spinejack, Vertaplex |
| Harmony Biosciences LLC | $23.37 | 2021 | |
| Globus Medical, INC. | $23.07 | 2025 | Instruments, Coalition Agx |
| Boston Scientific Corporation | $22.69 | 2025 | Wavewriter Alpha Prime 16 |
| Ebi, LLC | $22.65 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System, Spf Xl Iib Implantable Spinal Fusion Stimulator |
| Zimvie INC. | $15.81 | 2022 | |
| Sanara Medtech INC. | $15.15 | 2025 | Celleraterx |
| Ethicon INC. | $14.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ingraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.